Provide pathological evaluation services in compliance with multiple GLP requirements including those of the U.S. FDA, the Organisation for Economic Co-operation and Development (OECD), and China’s NMPA (formerly CFDA).
Comprehensive interpretation of pathological data and integrated pathology reports are provided by board-certified veterinary pathologists licensed in the United States and in-house veterinary pathologists licensed in China. Data collection is performed using the Provantis system in accordance with 21 CFR Part 11.
- Clinical Pathology: Biochemistry, Hematology, Coagulation, Urinalysis
- Necropsy: All commonly used laboratory animals
- Histoprocessing: H&E staining, Special staining, Immunohistochemistry
- Histopathological Evaluation
Muridda provides clients with safety evaluation services including general toxicology, safety pharmacology, reproductive and developmental toxicity, genetic toxicology, immunotoxicology, as well as pharmacokinetics and toxicokinetics, covering the entire process from drug discovery to IND and NDA submissions. Through cost-effective and efficient services, we help clients shorten experimental duration and reduce the cost of new drug research and development.
We have a professional team and practical experience in drug safety evaluation, capable of delivering high-quality data and rapid turnaround times to support various drug safety evaluation research. Toxicological studies are conducted in different animal species, and all procedures from dose design, experimental research to histology, pathology and clinical testing can be performed in accordance with non-GLP or GLP standards.